Whilst these findings are consistent with PPARγ-independent growth inhibition observed in some cancer types, it has been clearly demonstrated in other cases that thiazolidinedione agonists and 15dPGJ2-induced growth inhibition is PPARγ-dependent [21,25,26,42,43]. This evidence concerns the gene PPARG and cancer.